New real-time patient radiation dosimeter for use in radiofrequency catheter ablation.

patient dose peak skin dose photoluminescence sensor radiation skin dose radiophotoluminescence glass reference dosimeter (RPLD) real-time dosimeter

Journal

Journal of radiation research
ISSN: 1349-9157
Titre abrégé: J Radiat Res
Pays: England
ID NLM: 0376611

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 04 10 2018
pubmed: 10 1 2019
medline: 19 7 2019
entrez: 10 1 2019
Statut: ppublish

Résumé

In a previous study, we reported on a novel (prototype) real-time patient dosimeter with non-toxic phosphor sensors. In this study, we developed new types of sensors that were smaller than in the previous prototype, and clarified the clinical feasibility of our newly proposed dosimeter. Patient dose measurements obtained with the newly proposed real-time dosimeter were compared with measurements obtained using a calibrated radiophotoluminescence glass reference dosimeter (RPLD). The reference dosimeters were set at almost the same positions as the new real-time dosimeter sensors. We found excellent correlations between the reference RPLD measurements and those obtained using our new real-time dosimeter (r2 = 0.967). However, the new type of dosimeter was found to underestimate radiation skin dose measurements when compared with an RPLD. The most probable reason for this was the size reduction in the phosphor sensor of the new type of dosimeter. We believe that, as a result of reducing the phosphor sensor size, the backscattered X-ray irradiation was underestimated. However, the new dosimeter can accurately determine the absorbed dose by correcting the measured value with calibration factors. The calibration factor for the new type dosimeter was determined (by linear regression) to be ~1.15. New real-time patient dosimeter design would be an effective tool for the real-time measurement of patient skin doses during interventional radiology treatments.

Identifiants

pubmed: 30624747
pii: 5280419
doi: 10.1093/jrr/rry110
pmc: PMC6430253
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-220

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.

Références

Radiat Prot Dosimetry. 2017 Jun 1;175(1):31-37
pubmed: 27624894
Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
Med Phys. 2014 Oct;41(10):101913
pubmed: 25281965
J Radiat Res. 2018 Mar 1;59(2):225-232
pubmed: 29409055
AJR Am J Roentgenol. 2009 Dec;193(6):1680-5
pubmed: 19933664
Phys Med. 2016 Nov;32(11):1475-1478
pubmed: 27825653
Radiat Prot Dosimetry. 2011 Jan;143(1):69-73
pubmed: 20947586
J Appl Clin Med Phys. 2016 Jul 08;17(4):391-401
pubmed: 27455503
J Vasc Interv Radiol. 2012 Jan;23(1):11-8
pubmed: 22057151
Radiat Prot Dosimetry. 2014 Dec;162(3):224-9
pubmed: 24277872
J Radiat Res. 2014 Nov;55(6):1122-30
pubmed: 24968708
AJR Am J Roentgenol. 2009 Aug;193(2):559-69
pubmed: 19620457
AJR Am J Roentgenol. 2011 Apr;196(4):756-61
pubmed: 21427321
Radiol Phys Technol. 2009 Jan;2(1):58-61
pubmed: 20821130
J Radiat Res. 2010;51(2):97-105
pubmed: 20339253
Acta Radiol. 2009 Jun;50(5):474-81
pubmed: 19353341
AJR Am J Roentgenol. 2007 Oct;189(4):W224-7
pubmed: 17885036
Phys Med. 2015 Dec;31(8):929-933
pubmed: 26160701
AJR Am J Roentgenol. 2015 Aug;205(2):W202-6
pubmed: 26204308
AJR Am J Roentgenol. 2014 Apr;202(4):W335-42
pubmed: 24660731
Acta Radiol. 2012 Nov 1;53(9):1040-4
pubmed: 23024180
AJR Am J Roentgenol. 2011 Nov;197(5):W900-3
pubmed: 22021539
AJR Am J Roentgenol. 2013 Jan;200(1):138-41
pubmed: 23255753
AJR Am J Roentgenol. 2004 Oct;183(4):1111-4
pubmed: 15385315
Ann ICRP. 2013 Feb;42(1):1-125
pubmed: 23141687
AJR Am J Roentgenol. 2010 Nov;195(5):1175-9
pubmed: 20966324
Ann ICRP. 2000;30(2):7-67
pubmed: 11459599
AJR Am J Roentgenol. 2006 Mar;186(3):774-8
pubmed: 16498105
J Radiat Res. 2018 Mar 1;59(2):233-239
pubmed: 29136194
Phys Med. 2014 Dec;30(8):934-40
pubmed: 25277316

Auteurs

Mamoru Kato (M)

Department of Radiology and Nuclear Medicine, Research Institute for Brain and Blood Vessels - Akita, 6-10 Senshu-Kubota Machi, Akita, Akita, Japan.
Course of Radiological Technology, Health Sciences, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Sendai, Miyagi, Japan.

Koichi Chida (K)

Course of Radiological Technology, Health Sciences, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Sendai, Miyagi, Japan.

Masaaki Nakamura (M)

Course of Radiological Technology, Health Sciences, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Sendai, Miyagi, Japan.

Hideto Toyoshima (H)

Department of Radiology and Nuclear Medicine, Research Institute for Brain and Blood Vessels - Akita, 6-10 Senshu-Kubota Machi, Akita, Akita, Japan.

Ken Terata (K)

Department of Cardiology, Division of Internal Medicine, Research Institute for Brain and Blood Vessels - Akita, 6-10 Senshu-Kubota Machi, Akita, Akita, Japan.

Yoshihisa Abe (Y)

Department of Cardiology, Division of Internal Medicine, Research Institute for Brain and Blood Vessels - Akita, 6-10 Senshu-Kubota Machi, Akita, Akita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH